From £6.99 per month
ShareProphets
The one stop source for breaking news, expert analysis, and podcasts on fast-moving AIM and LSE listed shares

MINDING THE LSE’S BUSINESS

Join for as low as £6.99 per month

With ShareProphets’ membership, you receive:

• All premium articles

• Tom Winnifrith’s Bearcast

• Access to all the entire nearly 10 year archive

• ShareProphets Daily Newsletter

Latest News

Professor
premium content

Sunday Long Reads: Stolen Puppies, Tech Charity, Salman Rushdie good, Salman Rushdie bad, Too Tall Skyscrapers

Here are five long reads that have nothing to do with shares. Put the kettle on, find a comfy chair. You have the time, don't you?

TATE
premium content

As an investor, Tate and Lyle shares are still Tate and Smile for me!

A mere fifteen months ago, I wrote about why I was “warming up to Tate & Lyle (TATE)”. I concluded that article by observing that I made the share “a BUY compared to Friday’s close of just shy of a 675p share price”. How is the story now with Friday’s closing share price 788p a share (and the global supplier of food and beverage ingredients company founded over a hundred years ago pays a dividend as well).
Tumbleweed

Animated Chart: The Rise and Fall of Music Sales, by Format (1973-2021)

This eyeopening chart from Visual Capitalist shows, in animated form, that what used to be all vinyl is now all digital. But did you forget about 8 Tracks? And ringtones? Ringtones! Who paid for ringtones!
Gold
premium content

The View From The Montana Log-Cabin As Gold Battles A Pull-Back

Gold finished the week at $1866. Having suggested last week that it could go either way from $1864 at the time, I was wrong – it went nowhere. In the short term, it could head further south from here as corrective forces assert but so far it has held up rather well. Long term, I remain extremely bullish.
Top-10
premium content

Notes from Underground – Most read articles for the week ending 11 Feb 2023

The most-read non-Tom article this week is by Chris Bailey, Gold: you're indestructible (even if the price goes down sometimes)  at No 6 or No 14 including Bearcasts.

premium content

Journeo – positive trading update, still a bit of time to BUY

Technology for transport operators company Journeo (JNEO) has announced that 2022 revenue increased by 35% to £21.1 million, with profit “anticipated to be in line with market expectations” and “good earnings visibility for the current financial year”. So what of a share price which is now up to 133.5p?
Bearcast
premium content

Tom Winnifrith Bearcast: a failed and humble fund manager offers advice to a conceited successful one, Crispin Odey, over Advanced Oncotherapy

I discuss both Advanced Oncotherapy (AVO) where my target remains 0p. And I say that as the loyal owner of one share. Then also the green idiots suing Shell (SHEL) for not being green enough. Words almost fail me but, as usual, in the end they do not. I forgot to mention it but I commend to you my article on the utter bastardisation of democracy and Orwellian use of language by the Committee of the MCC, HERE
AMRQ
premium content

Amaroq Minerals – positive Vagar licence exploration results, Up on our share tip but still a BUY at 43.5p, target 60p

Amaroq Minerals (AMRQ) has announced exploration programme results from its Vagar licence in Greenland and that “current drill intersections suggest that a large tonnage Intrusion Related Gold system is in play”.
PZC
premium content

I finally get a chance to look at the latest set of numbers from PZ Cussons: BUY

Everything has been really busy recently, but it is always better to be busy than not. This is why I am - once again - playing a bit of catch up this weekend, which brings me today to PZ Cusson (PZC). I have written about the manufacturer of personal healthcare products and consumer goods a few times over the last year or two, usually concluding that a sub two quid share price is where I want to buy (more). And here we are again…
GoldfishShark

Video: Could We See a Precious Metals Buying Mania?

Trader David Brady is another gold bull whispering sweet nothings into the ear of our own Nigel Somerville.
BMV
premium content

Bluebird Merchant Ventures – good news from the Philippines and news from South Korea set to follow, Buy

Bluebird Merchant Ventures (BMV) states that it is delighted to announce that it has signed an agreement with a Philippine company, whose owners have decades of experience in mining, to develop the high grade Batangas gold project in the Philippines.
AVO
premium content

Advanced Oncotherapy: It Is Surely In Real Trouble Now, the Fat Lady awaits

It seems that no amount of ramping can help AIM-listed Advanced Oncotherapy (AVO) now. The company is in deep shit – and has essentially admitted as much. I would suggest also that the recent note from pay-as-you-go “researcher” (to be polite) Hardman is also an almighty sell signal. At the root of the problem is the cash-guzzling nature of the business, but with a 25p par price and the shares now at just 7.5p it is clear that shareholders are about to take a bath. Or the whole shooting match could follow fellow proton therapy outfit Rutherford Health (RUTH - ex-of the Aquis lobster pot) to the great central bank in the sky. Anyone holding is, in my view, insane.
GetAFix

Follow in the Footsteps of Giants and Don't Trouble the Minnows as Blighty Faces Bleakness.

Hello Share Chums. This old punter is of the belief the recent all-time high for the Footsie will keep going for longer. Therefore, staying in cash is now consigned to my recent history. However, I’m only considering the big 100 index here. The fate of lower value companies is not as encouraging.
ACC

Access Intelligence – how “delighted” to be about recent contract wins?

Describing itself as a “technology innovator delivering Software-as-a-Service solutions for the global marketing and communications industries”, Access Intelligence (ACC) states that it “is pleased to announce a number of contract wins across the globe in the last two months”. So what about these and a current over 3% higher share price response to 79p?
Bearcast
premium content

Tom Winnifrith Bearcast: a buy idea with 20% total return target + what would Ben Turney v1 make of Ben Turney v2 after Friday's nonsense?

In today's podcast I look at Afentra (AET) and Gary Newman's patience with obvious cretins, ScotGold (SGZ), Chill Brands (CHLL), Guild ESports (GILD), Genedrive (GDR) - a £62 million short - Kavango Resources (KAV) and BAT Industries (BATS).
GoldfishShark

Video: The Best Gold Bull Market I Have Ever Seen

Money manager Peter Grandich has a message that our own Nigel Somerville will be delighted to hear. Peter discusses the potential for this gold bull market and why it’s likely extraordinary. He says that Central Banks are buying at record levels, and many of those buying are doing it for safety reasons. He says that you should not bet against the Fed and don’t bet against central banks when it comes to gold and hence mining shares have yet to reflect what is happening, and are, arguably, as cheap as they can get regarding the price of gold.
ARB
premium content

Argo Blockchain is uninvestable says broker Fiske

I explained why I expected Argo (ARB) to go bust during 2023 yesterday HERE after scallywag CEO Peter Wall jumped ship. I am not to the only bear in town. Jeremy Smith of broker Fiske does not hold back, opining:
GDR
premium content

Genedrive CEO engages in sordid BB ramping - bailout discounted placing ahoy

David Budd the, CEO of Genedrive plc (GDR) has been out ramping this week with an RNS that one of its devices has received a preliminarily recommendation for use in the NHS. Not only that but he’s been posting over on the LSE asylum to groom the posters over there:
SGZ
premium content

The BBC bums its readers with the fake news pump that got Scotgold’s bailout placing away

I wonder if BBC journalist David Henderson, Pravda’s business correspondent in the second world post industrial transgender friendly shithole that is Scotland, feels any guilt about losing folks stacks of cash by publishing fake news? Ahead of a ramptastic and wholly fictitious article about Scotgold (SGZ), an AIM listed company teetering on a financial precipice the shares traded at 44.5p. Then Henderson published as you can see HERE.
Subscribe to our newsletter

Daily digest of our latest stories.



Search ShareProphets

Market News

Complete Coverage

Recent Comments

Most Read in the Past Seven Days

That Was the Week that Was

 

ANP

Anpario – a recovery Buy?...

Thursday »

Cat_Fixing_Lightbulb

Bearcast issue update: all should be well

 

ORCP

Oracle Power: Cynical Foul

Time left: 17:43:01